Literature DB >> 20931202

[Tuberculosis-associated posterior uveitis].

N Negraszus1, U Pleyer.   

Abstract

The commercially available interferon gamma release assays T-SPOT.TB and QuantiFERON-TB Gold/QuantiFERON-TB Gold In-Tube may be important, besides the direct detection with culturing, PCR or the Mantoux skin test, for the diagnosis of tuberculosis as a possible cause of uveitis. It is important to know the limitations of these tests to get a fast and reliable diagnosis which may necessitate initiation of causative treatment of the tuberculosis to prevent further damage to the eye and to avoid multi-drug resistant tuberculosis strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20931202     DOI: 10.1007/s00347-010-2270-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.

Authors:  Giovanni Ferrara; Monica Losi; Roberto D'Amico; Pietro Roversi; Roberto Piro; Marisa Meacci; Barbara Meccugni; Ilaria Marchetti Dori; Alessandro Andreani; Barbara Maria Bergamini; Cristina Mussini; Fabio Rumpianesi; Leonardo M Fabbri; Luca Richeldi
Journal:  Lancet       Date:  2006-04-22       Impact factor: 79.321

2.  Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

Authors:  J Y Lee; H J Choi; I-N Park; S-B Hong; Y-M Oh; C-M Lim; S D Lee; Y Koh; W S Kim; D S Kim; W D Kim; T S Shim
Journal:  Eur Respir J       Date:  2006-04-12       Impact factor: 16.671

Review 3.  Intraocular tuberculosis--an update.

Authors:  Vishali Gupta; Amod Gupta; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 6.048

Review 4.  Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge.

Authors:  Robert Loddenkemper; Barbara Hauer
Journal:  Dtsch Arztebl Int       Date:  2010-01-07       Impact factor: 5.594

5.  Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study.

Authors:  D Goletti; S Carrara; D Vincenti; C Saltini; E Busi Rizzi; V Schininà; G Ippolito; M Amicosante; E Girardi
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

6.  Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors:  Dick Menzies; Madhukar Pai; George Comstock
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

7.  Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.

Authors:  Roland Diel; Robert Loddenkemper; Karen Meywald-Walter; Stefan Niemann; Albert Nienhaus
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

8.  Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay.

Authors:  Marcus Ang; Hla Myint Htoon; Soon-Phaik Chee
Journal:  Ophthalmology       Date:  2009-07       Impact factor: 12.079

9.  Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis.

Authors:  Cynthia B E Chee; Suay H Gan; Kyi W Khinmar; Timothy M Barkham; Chwee K Koh; Shen Liang; Yee T Wang
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

10.  QuantiFERON TB-Gold--a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis.

Authors:  Friederike Mackensen; Matthias D Becker; Ute Wiehler; Regina Max; Alexander Dalpke; Stefan Zimmermann
Journal:  Am J Ophthalmol       Date:  2008-08-21       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.